2-(2-Methyl-3-nitrophenyl)thiophene | 546094-12-6

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: 2-(2-Methyl-3-nitrophenyl)thiophene
• CAS: 546094-12-6
• 化学式: C₁₁H₉NO₂S
• 分子量: 219.264
• InChiKey: ZHWLFNHBTUFORO-UHFFFAOYSA-N

物化性质

• 沸点：
  324.3±30.0 °C(Predicted)
• 密度：
  1.272±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  3.5
• 重原子数：
  15
• 可旋转键数：
  1
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.09
• 拓扑面积：
  74.1
• 氢给体数：
  0
• 氢受体数：
  3

反应信息

• 作为反应物：
  描述：

  2-(2-Methyl-3-nitrophenyl)thiophene 在 盐酸 、 乙胺嗪 、 铁粉 、 mercury(II) oxide 作用下， 以 四氢呋喃 、 乙醇 、 二氯甲烷 为溶剂， 反应 52.0h， 生成 N-(2-methyl-3-thiophen-2-ylphenyl)-4,5-dihydro-1H-imidazol-2-amine
  参考文献：
  名称：

  Discovery of a series of (4,5-Dihydroimidazol-2-yl)-biphenylamine 5-HT7 agonists

  摘要：

  A novel (4,5-dihydroimidazol-2-yl)-biphenylamine series of 5-HT7 agonist compounds was developed from a structurally related lead compound 1. The newly discovered series is exemplified by compound 2 that possesses high affinity for 5-HT7 receptors and shows intrinsic agonist activity in functional assays. This new series has significant alpha(1) and alpha(2) activities perhaps due to the presence of the 2-aminoimidazoline moiety. (C) 2002 Elsevier Science Ltd. All rights reserved.

  DOI：

  10.1016/s0960-894x(02)00925-3
• 作为产物：
  描述：

  2-噻吩硼酸 、 2-溴-6-硝基甲苯 在 四(三苯基膦)钯 、 cesium fluoride 作用下， 以 乙二醇二甲醚 为溶剂， 反应 4.0h， 生成 2-(2-Methyl-3-nitrophenyl)thiophene
  参考文献：
  名称：

  Discovery of a series of (4,5-Dihydroimidazol-2-yl)-biphenylamine 5-HT7 agonists

  摘要：

  A novel (4,5-dihydroimidazol-2-yl)-biphenylamine series of 5-HT7 agonist compounds was developed from a structurally related lead compound 1. The newly discovered series is exemplified by compound 2 that possesses high affinity for 5-HT7 receptors and shows intrinsic agonist activity in functional assays. This new series has significant alpha(1) and alpha(2) activities perhaps due to the presence of the 2-aminoimidazoline moiety. (C) 2002 Elsevier Science Ltd. All rights reserved.

  DOI：

  10.1016/s0960-894x(02)00925-3

文献信息

• 2-(substituted-phenyl)amino-imidazoline derivatives
  申请人：——

  公开号：US20030036655A1

  公开（公告）日：2003-02-20

  This invention relates to IP receptor antagonists selected from the group of compounds represented by Formula I: 1 where: R 1 is a group represented by formula (A), (B) or (C); 2 d other substituents as defined in the specification, and their pharmaceutically acceptable ts or crystal forms thereof; and pharmaceutical compositions containing them; and methods their use as therapeutic agents.

  本发明涉及IP受体拮抗剂，其选自由式I所表示的化合物组中：其中：R1是由式(A)、(B)或(C)表示的基团；2d是根据说明书中定义的其他取代基，以及它们的药学上可接受的盐或晶体形式；以及包含它们的药物组合物；以及将它们用作治疗剂的方法。
• 2-(Substituted-phenyl)amino-imidazoline derivatives
  申请人：——

  公开号：US20030229123A1

  公开（公告）日：2003-12-11

  This invention relates to IP receptor antagonists selected from the group of compounds represented by Formula I: 1 where: R 1 is a group represented by formula (A), (B) or (C); 2 d other substituents as defined in the specification, and their pharmaceutically acceptable ts or crystal forms thereof; and pharmaceutical compositions containing them; and methods their use as therapeutic agents.

  本发明涉及从由公式I所代表的化合物组中选择的IP受体拮抗剂：1其中：R1是由公式（A），（B）或（C）表示的基团；2d是在规范中定义的其他取代基，以及它们的药学上可接受的盐或晶体形式；以及包含它们的药物组合物；以及它们作为治疗剂的使用方法。
• 2-(Arylphenyl)amino-imidazoline derivatives
  申请人：F. HOFFMANN-LA ROCHE AG

  公开号：EP0902018A2

  公开（公告）日：1999-03-17

  The invention relates to IP receptor antagonists selected from the group of compounds represented by formula wherein R1 is a group represented by formula (A), (B) or (C): and other substituents as defined in the specification, and their pharmaceutically acceptable salts, crystal forms therof and pharmaceutical compositions containing them.

  本发明涉及 IP 受体拮抗剂，这些受体选自由式表示的化合物组。 式中 R1为式(A)、(B)或(C)所代表的基团： 和说明书中定义的其它取代基的化合物，以及它们的药学上可接受的盐、它们的晶体形式和含有它们的药物组合物。
• US6184242B1
  申请人：——

  公开号：US6184242B1

  公开（公告）日：2001-02-06
• US6472536B1
  申请人：——

  公开号：US6472536B1

  公开（公告）日：2002-10-29